• Mutation; HGNC; HGNC:9588; PTEN; Simple; c.253+1G>T; ClinVar=VCV000189475; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
  
• Mutation; HGNC; HGNC:9884; RB1; Simple; c.265_2787del2523; Zygosity=Homozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
  

PubMed=16170671; DOI=10.1007/s10585-005-0745-1
Sharon A. Vantyghem, Alison L. Allan, Carl O. Postenka, Waleed Al-Katib, Michael Keeney, Alan B. Tuck, Ann F. Chambers;
A new model for lymphatic metastasis: development of a variant of the MDA-MB-468 human breast cancer cell line that aggressively metastasizes to lymph nodes.
Clin. Exp. Metastasis 22:351-361(2005)

PubMed=18262045; DOI=10.1016/j.cancergencyto.2007.05.030
Jie Xu, Ann F. Chambers, Alan B. Tuck, David I. Rodenhiser;
Molecular cytogenetic characterization of human breast cancer cell line MDA-MB-468 and its variant 468LN, which displays aggressive lymphatic metastasis.
Cancer Genet. Cytogenet. 181:1-7(2008)

PubMed=20084286; DOI=10.1371/journal.pone.0008665; PMCID=PMC2801616
Joseph D. Andrews, Wendy Kennette, Jenna Pilon, Alexandra Hodgson, Alan B. Tuck, Ann F. Chambers, David I. Rodenhiser;
Multi-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number.
PLoS ONE 5:e8665.1-e8665.17(2010)